Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Giner

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 27, 2018
Molecular subtypes in early colorectal cancer associated with clinical features and patient prognosisM Gil-Raga, E Jantus-Lewintre, S Gallach, et al.
Revista Clinica Espanola|November 21, 2019
Have the Government's prescription algorithm and the 2013 American College of Cardiology/American Heart Association guidelines for managing dyslipidaemia influenced the management of dyslipidaemia? The MEJORALO-CV ProjectV Giner Galvañ, I Bonig Trigueros, L Fácila Rubio, et al.
Revue Des Maladies Respiratoires|March 13, 1998
[Prognostic factors in advanced stage non-small cell bronchial cancer: experiences of the European Lung Cancer Working Party]J P Sculier, M Paesmans, P Libert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Phase III randomized trial comparing cisplatin and carboplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer. European Lung Cancer Working PartyJ P Sculier, M Paesmans, J Thiriaux, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2000
A comparison of methods of calculation for estimating carboplatin AUC with a retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancer. European Lung Cancer Working PartyJ P Sculier, M Paesmans, J Thiriaux, et al.
European Journal of Cancer Care|January 22, 2013
Effectiveness of daily versus non-daily granulocyte colony-stimulating factors in patients with solid tumours undergoing chemotherapy: a multivariate analysis of data from current practiceD Almenar Cubells, C Bosch Roig, E Jiménez Orozco, et al.
Lung Cancer (Amsterdam, Netherlands)|December 1, 1996
Prognostic factors for response to chemotherapy containing platinum derivatives in patients with unresectable non-small cell lung cancer. (NSCLC)M Borges, J P Sculier, M Paesmans, et al.
Lung Cancer (Amsterdam, Netherlands)|August 11, 2004
Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapyT Berghmans, J J Lafitte, J Thiriaux, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 4, 2007
A phase III randomised trial comparing sequential chemotherapy using cisplatin-based regimen and paclitaxel to cisplatin-based chemotherapy alone in advanced non-small-cell lung cancerJ P Sculier, J J Lafitte, J Lecomte, et al.
British Journal of Cancer|November 27, 2001
A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibioticsJ P Sculier, M Paesmans, J Lecomte, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 27, 2018
Molecular subtypes in early colorectal cancer associated with clinical features and patient prognosisM Gil-Raga, E Jantus-Lewintre, S Gallach, et al.
Revista Clinica Espanola|November 21, 2019
Have the Government's prescription algorithm and the 2013 American College of Cardiology/American Heart Association guidelines for managing dyslipidaemia influenced the management of dyslipidaemia? The MEJORALO-CV ProjectV Giner Galvañ, I Bonig Trigueros, L Fácila Rubio, et al.
Revue Des Maladies Respiratoires|March 13, 1998
[Prognostic factors in advanced stage non-small cell bronchial cancer: experiences of the European Lung Cancer Working Party]J P Sculier, M Paesmans, P Libert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Phase III randomized trial comparing cisplatin and carboplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer. European Lung Cancer Working PartyJ P Sculier, M Paesmans, J Thiriaux, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2000
A comparison of methods of calculation for estimating carboplatin AUC with a retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancer. European Lung Cancer Working PartyJ P Sculier, M Paesmans, J Thiriaux, et al.
European Journal of Cancer Care|January 22, 2013
Effectiveness of daily versus non-daily granulocyte colony-stimulating factors in patients with solid tumours undergoing chemotherapy: a multivariate analysis of data from current practiceD Almenar Cubells, C Bosch Roig, E Jiménez Orozco, et al.
Lung Cancer (Amsterdam, Netherlands)|December 1, 1996
Prognostic factors for response to chemotherapy containing platinum derivatives in patients with unresectable non-small cell lung cancer. (NSCLC)M Borges, J P Sculier, M Paesmans, et al.
Lung Cancer (Amsterdam, Netherlands)|August 11, 2004
Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapyT Berghmans, J J Lafitte, J Thiriaux, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 4, 2007
A phase III randomised trial comparing sequential chemotherapy using cisplatin-based regimen and paclitaxel to cisplatin-based chemotherapy alone in advanced non-small-cell lung cancerJ P Sculier, J J Lafitte, J Lecomte, et al.
British Journal of Cancer|November 27, 2001
A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibioticsJ P Sculier, M Paesmans, J Lecomte, et al.
Pageof 8